Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma (vol 15, pg 737, 2015)

被引：3
|
作者：
Richardson, P. G. [1 ]
Laubach, J. P. [1 ]
Lonial, S. [1 ]
机构：
[1] Univ Navarra Clin, IDISNA, CIMA, Pamplona, Spain
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2015年 / 15卷 / 09期
关键词：
D O I：
10.1586/14737140.2015.1071726
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1121 / 1121
页数：1
相关论文
共 50 条
  • [31] Treatment of relapsed and refractory multiple myeloma in the era of novel agents
    van de Donk, Niels W. C. J.
    Lokhorst, Henk M.
    Dimopoulos, Meletios
    Cavo, Michele
    Morgan, Gareth
    Einsele, Hermann
    Kropff, Martin
    Schey, Steve
    Avet-Loiseau, Herve
    Ludwig, Heinz
    Goldschmidt, Hartmut
    Sonneveld, Pieter
    Johnsen, Hans E.
    Blade, Joan
    San-Miguel, Jesus F.
    Palumbo, Antonio
    CANCER TREATMENT REVIEWS, 2011, 37 (04) : 266 - 283
  • [32] Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma
    Yu-bo Zhou
    Yang-ming Zhang
    Hong-hui Huang
    Li-jing Shen
    Xiao-feng Han
    Xiao-bei Hu
    Song-da Yu
    An-hui Gao
    Li Sheng
    Ming-bo Su
    Xiao-li Wei
    Yue Zhang
    Yi-fan Zhang
    Zhi-wei Gao
    Xiao-yan Chen
    Fa-jun Nan
    Jia Li
    Jian Hou
    Acta Pharmacologica Sinica, 2022, 43 : 1091 - 1099
  • [33] Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma
    Zhou, Yu-bo
    Zhang, Yang-ming
    Huang, Hong-hui
    Shen, Li-jing
    Han, Xiao-feng
    Hu, Xiao-bei
    Yu, Song-da
    Gao, An-hui
    Sheng, Li
    Su, Ming-bo
    Wei, Xiao-li
    Zhang, Yue
    Zhang, Yi-fan
    Gao, Zhi-wei
    Chen, Xiao-yan
    Nan, Fa-jun
    Li, Jia
    Hou, Jian
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (04) : 1091 - 1099
  • [34] The use of novel agents in the treatment of relapsed and refractory multiple myeloma
    J P Laubach
    A Mahindra
    C S Mitsiades
    R L Schlossman
    N C Munshi
    I M Ghobrial
    N Carreau
    T Hideshima
    K C Anderson
    P G Richardson
    Leukemia, 2009, 23 : 2222 - 2232
  • [35] The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
    San-Miguel, Jesus F.
    Einsele, Hermann
    Moreau, Philippe
    ADVANCES IN THERAPY, 2016, 33 (11) : 1896 - 1920
  • [36] Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
    Mu, Song
    Kuroda, Yoshiaki
    Shibayama, Hirohiko
    Hino, Masayuki
    Tajima, Takeshi
    Corrado, Claudia
    Lin, Rong
    Waldron, Edward
    Binlich, Florence
    Suzuki, Kenshi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (02) : 153 - 161
  • [37] The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
    Jesus F. San-Miguel
    Hermann Einsele
    Philippe Moreau
    Advances in Therapy, 2016, 33 : 1896 - 1920
  • [38] THE NOVEL PAN-DEACETYLASE INHIBITOR PANOBINOSTAT INDUCES ALTERNATIVE PATHWAYS OF APOPTOSIS IN HEPATOCELLULAR CARCINOMA MODELS
    Di Fazio, P.
    Schneider-Stock, R.
    Wissniowski, T.
    Gahr, S.
    Neureiter, D.
    Ocker, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S190 - S191
  • [39] Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma
    Song Mu
    Yoshiaki Kuroda
    Hirohiko Shibayama
    Masayuki Hino
    Takeshi Tajima
    Claudia Corrado
    Rong Lin
    Edward Waldron
    Florence Binlich
    Kenshi Suzuki
    European Journal of Clinical Pharmacology, 2016, 72 : 153 - 161
  • [40] Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
    Jayaweera, Shansa Pranami E.
    Wanigasinghe Kanakanamge, Sacheela Prasadi
    Rajalingam, Dharshika
    Silva, Gayathri N.
    FRONTIERS IN ONCOLOGY, 2021, 11
12345